or
forgot password

    • cancer clinical trials in arkansas

    • Combination Chemotherapy in Treating Women With Breast Cancer
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Breast Cancer
    S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Neuroendocrine Carcinoma of the Skin
    S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Little Rock, Arkansas 72205
    Lung Cancer
    S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Adult Meningioma
    Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Colorectal Cancer
    506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Leukemia
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Hembree Mercy Cancer Center at St. Edward Mercy Medical Center

    Trial Locations
    Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Melanoma (Skin)
    Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Stage IV Melanoma, Stage III Melanoma, Recurrent Melanoma
    S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Malignant Mesothelioma
    Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Leukemia
    S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Little Rock, Arkansas 72205
    Lymphoma
    S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Bladder Cancer
    4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Multiple Myeloma and Plasma Cell Neoplasm
    Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
    Highlands Oncology Group
    Springdale, Arkansas 72764
    Hypercalcemia of Malignancy, Lung Cancer, Metastatic Cancer, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant
    Arkansas Children's Hospital
    Little Rock, Arkansas 72202-3591
    Graft Versus Host Disease, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Breast Associates

    Trial Locations
    Breast Associates
    Surgical Associates
    Northeast Arkansas Clinic
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Breast Cancer
    S9903: Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Melanoma (Skin), Metastatic Cancer
    S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung Cancer
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Lung Cancer
    Combination Chemotherapy in Treating Children or Adolescents With Newly Diagnosed Stage III or Stage IV Lymphoblastic Lymphoma
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Lymphoma
    S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Esophageal Cancer, Gastric Cancer
    Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Leukemia
    Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Leukemia
    S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Gastrointestinal Stromal Tumor
    Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Leukemia, Lymphoma
    S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Leukemia